In the increasingly complex landscape of clinical research and clinical practice, hospital staff face the daunting challenge of taking evidence-based decisions, informed by insights from dispersed clinical data. Identifying patients and enhancing healthcare delivery are often hindered by time constraints, intricate eligibility criteria and complex registration practices of electronic medical records. Moreover, crucial information is often buried in free text, and even in ideal situations the sheer volume of data is too extensive to thoroughly review.
Acknowledging these challenges, we will present transformative approaches to achieve operational efficiencies, generate clinical insights, and ultimately benefit patients, by harnessing the power of electronic medical records.
Join us as we explore how leading researchers from across Europe have utilized innovative solutions to improve their processes and advance their healthcare practices.
Register to Attend
Key learning objectives
- Understand how to leverage electronic medical records to create patient cohorts and collect clinical information to yield insights that support cost savings, real-world evidence, treatment variations, safety profiles, and patient pathway enhancements
- Learn from use cases where technology has successfully identified suitable patient populations, including previously undiagnosed patients, including those suffering from rare diseases
- Discover strategies to overcome the complexities of patient recruitment in clinical trials by leveraging AI-driven algorithms and advanced data analytics platforms
- Gain knowledge on targeting specific patient populations for research, thereby reducing the workload on site staff in finding eligible participants
Speakers:
Michal Janota – Operations Director, International Clinical Research Centre, Czech Republic. Michal Janota is the Vice-head for Operations of the International Clinical Research Center of the Saint Anne´s University Hospital in Brno.He graduated from the Faculty of Science, Masaryk University, Brno, the Czech Republic. During his studies, he was working for the Regional Development Research Center at Masaryk University where he led the administration office and was responsible for managing grants/commercial projects and everyday operations.Before he joined FNUSA-ICRC in 2011 he worked in the private sector as a Project manager of financial subsidies for small and medium enterprises focused mainly on technologies investments and HW/SW solutions development.Since 2014 he is leading strategic projects of developing specific research information systems and data infrastructure for FNUSA-ICRC. He leads the development of a core-facilities platform that will serve within Horizon funded Alliance4Life network for 11 institutions for offering laboratory services.In 2021 he became responsible for coordinating the cooperation with IQVIA and implementing the pilot project of IQVIA Patient Finder in FNUSA-ICRC.
Dr. Jesper van Breeschoten – Pharmacist, Haga Hospital, The Hague. Jesper van Breeschoten holds Master’s degrees in Pharmacy from the University of Utrecht and Health Economics Policy and Law from Erasmus University Rotterdam. He began his career as a PhD student at the Dutch Institute for Clinical Auditing (DICA) and Amsterdam University Medical Centre, VUMC. In 2023, he obtained his PhD with his thesis named “Evaluation of Systemic Therapy for Advanced Melanoma: Analyses of the Dutch Melanoma Treatment Registry”. Presently, Jesper serves as a pharmacist at Haga Hospital, The Hague, and conducts research at the National Coordination Center of Medicines (LCG).
Kim van der Velden – PhD student urology / oncology – Department of urology, Radboud University Medical Center. Kim van der Velden holds a Bachelor’s degree in Biomedical Sciences and a Premaster in Medicine from the Radboud University in Nijmegen. She is currently studying for her Master’s degree in Medicine. She began her career as a PhD student at the Department of Urology of the Radboud University Medical Center (RUMC) Nijmegen in 2023. For her PhD thesis, she is studying the efficacy, efficiency and quality of care in metastatic hormone sensitive (mHSPC) and castration resistant prostate cancer (CRPC) in real world clinical practice in the Netherlands, within the CAPRI-3 study.
Jolijn van Leeuwen – PhD student, Department of Nephrology, Leiden University Medical Center. Jolijn van Leeuwen holds a Master’s degree in Medicine from the Amsterdam University Medical Center, AMC. She is currently a PhD student at Nephrology department of the Leiden University Medical Center where she studies “Innovation of treatment in ANCA-associated vasculitis” with a focus on real world evidence. To identify patients with ANCA-associated vasculitis, a rare and heterogenous disease, she developed and validated a query using the CT-cue patient finder.
